Narrowband UV-B phototherapy vs photochemotherapy in the treatment of chronic plaque-type psoriasis: A paired comparison study

Archives of Dermatology

Volumn 135, Issue 5, 1999, Pages 519-524

  Tanew, Adrian ^a   Radakovic Fijan, Sonja ^a   Schemper, Michael ^b   Hönigsmann, Herbert ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXSALEN;

ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; PUVA; RADIATION DOSE; TREATMENT OUTCOME; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

CHRONIC DISEASE; HUMANS; PHOTOCHEMOTHERAPY; PSORIASIS; ULTRAVIOLET THERAPY;

EID: 0032930787     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.135.5.519     Document Type: Article

References (35)

1. Hönigsmann H, Fritsch P, Jaschke E. UV-Therapie der Psoriasis. Halbseitenvergleich zwischen oraler Photochemotherapie (PUVA) und selektiver UV-Phototherapie (SUP). Z Hautkr. 1977;52:1078-1082.
2. Brenner W, Jaschke E, Hönigsmann H. UV-B-Phototherapie der Psoriasis. Z Hautkr. 1983; 58:1113-1124.
3. Boer J, Hermans J, Schothorst AA, Suurmond D. Comparison of phototherapy (UV-B) and photochemotherapy (PUVA) for clearing and maintenance therapy of psoriasis. Arch Dermatol. 1984;120:52-57.
4. Morison WL. Combination of methoxsalen and ultraviolet B (UVB) versus UVB radiation alone in treatment of psoriasis: a bilateral comparison study. Photodermatol Photoimmunol Photomed. 1995;11:6-8.
5. Slaper H, Schothorst AA, van der Leun JC. Risk evaluation of UVB therapy for psoriasis: comparison of calculated risk for UVB therapy and observed risk in PUVA-treated patients. Photodermatology. 1986;3:271-283.
6. Studniberg HM, Weller P. PUVA, UVB, psoriasis, and nonmelanoma skin cancer. J Am Acad Dermatol. 1993;29:1013-1022.
7. Stern RS, Laird N. The carcinogenic risk of treatments for severe psoriasis. Cancer. 1994;73:2759-2764.
8. van Weelden H, van der Leun JC. Improving the effectiveness of photo- therapy for psoriasis [abstract]. Br J Dermatol. 1984;111:484.
9. van der Leun JC, van Weelden H. UV-B phototherapy: Principles, radiation sources, regimens. Curr Probl Dermatol. 1986;15:39-51.
10. Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol. 1981;76:359-362.
11. Fischer T, Alsins J, Berne B. Ultraviolet-action spectrum and evaluation of ultraviolet lamps for psoriasis healing. Int J Dermatol. 1984;23:633-637.
12. Green C, Ferguson J, Lakshmipathi T, Johnson BE. 311 nm UVB phototherapy: n effective treatment for psoriasis. Br J Dermatol. 1988;119:691-696.
13. van Weelden H, Baart de la Faille H, Young E, van der Leun JC. A new development in UVB phototherapy of psoriasis. Br J Dermatol. 1988;119:11-19.
14. Karvonen J, Kokkonen E-L, Ruotsalainen E. 311 nm UVB lamps in the treatment of psoriasis with the Ingram regimen. Acta Derm Venereol. 1989;69:82-85.
15. Larkö O. Treatment of psoriasis with a new UVB-lamp. Acta Derm Venereol. 1989; 69:357-359.
16. Barth J, Pinzer B. Therapie der Psoriasis mit dem UV-Strahler Philips TL-01. Dermatol Monatsschr. 1990;176:707-710.
17. Picot E, Meunier L, Picot-Debeze MC, et al. Treatment of psoriasis with a 311-nm UVB lamp. Br J Dermatol. 1992;127:509-512.
18. Storbeck K, Hölzle E, Schürer N, et al. Narrow-band UVB (311 nm) versus conventional broad-band UVB with and without dithranol in phototherapy for psoriasis. J Am Acad Dermatol. 1993; 28: 227-231.
19. Coven TR, Burack LH, Gilleaudeau P, et al. Narrowband UV-B produces superior clinical and histopathological resolution of moderate-to-severe psoriasis in patients compared with broad-band UV-B. Arch Dermatol. 1997;133:1514-1522.
20. van Weelden H, Baart de la Faille H, Young E, van der Leun JC. Comparison of narrow-band UV-B phototherapy and PUVA photochemotherapy in the treatment of psoriasis. Acta Derm Venereol. 1990;70:212-215.
21. Green C, Lakshmipathi T, Johnson BE, Ferguson J. A comparison of the efficacy and relapse rates of narrowband UVB (TL 01) monotherapy vs. etretinate (reTL-01) vs. etretinate-PUVA (re-PUVA) in the treatment of psoriasis patients. Br J Dermatol. 1992;127:5-9.
22. Fredriksson T, Pettersson U. Severe psoriasis: oral therapy with a new retinoid. Dermatologica .1978;157:238-244.
23. Wolff K, Gschnait F, Hönigsmann H et al. Phototesting and dosimetry for photochemotherapy. Br J Dermatol. 1977;96:1-10.
24. George SA, Ferguson J. Lesional blistering following narrow-band (TL-01) UVB phototherapy for psoriasis: a report of four cases. Br J Dermatol. 1992;127: 445-446.
25. Hofer A, Fink-Puches R, Kerl H, Wolf P. Comparison of phototherapy with near vs. far erythemogenic doses of narrow-band ultraviolet B in patients with psoriasis. Br J Dermatol. 1998;138:96-100.
26. Alora MBT, Taylor CR. Narrow-band (311nm) UVB phototherapy: an audit of the first year's experience at the Massachusetts General Hospital. Photodermatol Photoimmunol Photomed. 1997;13:82-84.
27. Grupper C, Berretti B. Tar, ultraviolet light, PUVA, and cancer. J Am Acad Dermatol. 1980;3:643-546.
28. Larkö O, Swanbeck G. Is UVB treatment of psoriasis safe? A study of extensively UVB-treated psoriasis patients compared with a matched control group. Acta Derm Venereol. 1982;62:507-512.
29. Flindt-Hansen H, McFadden N, Eeg-Larsen T, Thune P. Effect of a new narrow-band UVB lamp on photocarcinogenesis in mice. Acta Derm Venereol. 1991;71: 245-248.
30. Wulf HC, Hansen AB, Bech-Thomsen N. Differences in narrow-band ultraviolet B and broad-spectrum ultraviolet photocarcinogenesis in lightly pigmented hairless mice. Photodermatol Photoimmunol Photomed. 1994;10:192-197.
31. Gibbs NK, Traynor NJ, MacKie RM, Campbell I, Johnson BE, Ferguson J. The phototumorigenic potential of broad-band (270-350 nm) and narrow-band (311-313 nm) phototherapy sources cannot be predicted by their edematogenic potential in hairless mouse skin. J Invest Dermatol. 1995;104:359-363.
32. Young AR. Carcinogenicity of UVB phototherapy assessed. Lancet. 1995;345: 1431-1432.
33. De Gruijl FR. Long-term side effects and carcinogenesis risk in UVB therapy. In: Hönigsmann H, Jori G, Young AR, eds. The Fundamental Bases of Phototherapy. Milan, Italy: OEMF; 1996:153-70.
34. Tzung TY, Rünger TM. Assessment of DNA damage induced by broadband and narrowband UVB in cultured lymphoblasts and keratinocytes using the comet assay. Photochem Photobiol. 1998;67:647-650.
35. Stern RE. Narrowband UV-B and psoriasis. Arch Dermatol. 1997;133: 1387-1388.